Header image

Neuroscience session-1: Psychedelics in Depression: Friend or Foe?

Tracks
Sala dos Actos - Nobel Room
Thursday, June 4, 2026
8:30 - 10:00
Sala dos Actos - Nobel Room

Speaker

Agenda Item Image
Albino J. Oliveira-Maia
Director
Champalimaud Foundation

Beyond trials in psychedelic medicine: ethics, implementation and equity

8:30 - 9:00

Biography

Albino J. Oliveira Maia, MD, MPH, PhD. Albino J. Oliveira Maia trained in medicine at the Faculty of Medicine of the University of Porto, and then did doctoral and post-doctoral work in Neuroscience at Duke University and the Champalimaud Foundation, and completed a master’s degree in public health at Harvard University. After academic training, Albino specialized in Psychiatry and worked as a Psychiatrist in Lisbon. He is currently Director of the Neuropsychiatry Unit at the Champalimaud Clinical Center, Director of the Digital Neurotherapeutics Centre at the Centre for Restorative Neurotechnology, PI at the Neuroscience of Disease Programme, and professor of Psychiatry and Neuroscience at NOVA Medical School in Lisbon. Albino is also coordinator of the Psychiatry Working Group at the Office for the National Exam for Access to Specialty Training (Portugal), President-elect of the Portuguese Society of Psychiatry and Mental Health, President of the Scientific Council for the Portuguese OCD Foundation and President of the Ethics Committee at the Institute for Addictive Behaviors and Addictions.
Agenda Item Image
Luisa Pinto
Principal Investigator
University Of Minho

Targeting Adult Hippocampal Cytogenesis: Psilocybin's Role in Depression Therapy

9:00 - 9:30

Biography

Luisa Pinto (PhD) has graduated in Biochemistry by the University of Coimbra and performed an internship at the Karolinska Institute (Sweden) on therapeutic tools for Parkinson’s Disease. She obtained a PhD in Neurosciences by the Ludwig-Maximilians-Universität München (Germany) in 2008, under the supervision of Dr. Magdalena Goetz, and did then post-doctoral research in the lab of Prof. Nuno Sousa, at the Life and Health Sciences Research Institute (ICVS), University of Minho (Portugal). She is currently a Principal Investigator with tenure and team coordinator of the “Brain circuits and neuron-glia adaptations” thematic line at ICVS, focusing on novel therapeutics for Depression and Neurodegenerative Disorders. She is also an Invited Assistant Professor at the School of Medicine, University of Minho, and member of the Direction Board of ICVS. Pinto is CEO of a start-up company “BNML – Behavioural & Molecular Lab”. She authored and co-authored over 90 scientific publications, cited above 3900 times.
Inês Almeida
Phd Student
Nova Medical School-nova University Of Lisbon

Carotid body ablation improved non-motor dysfunction in a mouse model of Parkinson's disease

9:30 - 9:45

Biography

Gabriela Ribeiro
Assistant Professor
Nova Medical School, Faculdade De Ciências Médicas

Linking metabolic state to sweet taste perception: influence of food reward sensitivity.

9:45 - 10:00

Biography


Chair

Agenda Item Image
Luisa Pinto
Principal Investigator
University Of Minho

Rita Teodoro

loading